Structure-activity relationships of fluorene compounds inhibiting HCV variants-Reference-Cited by-同舟云学术

Structure-activity relationships of fluorene compounds inhibiting HCV variants

Published:2020-02 Issue: Volume:174 Page:104678
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Kim Hee Sun,You Youngsu,Mun Jaegon,Gadhe Changdev G.,Moon Heejo,Lee Jae Seung,Pae Ae Nim,Kohara Michinori,Keum Gyochang,Kim Byeong Moon,Jang Sung Key

Funder

National Research Foundation

Ministry of Science and ICT

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference36 articles.

1. Fluorene Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Therefor, and Pharmaceutical Composition Comprising Same as Effective Ingredient for Preventing or Treating Hcv-Related Disease;Kim,2019

2. Potent hepatitis C inhibitors bind directly to NS5A and reduce its affinity for RNA;Ascher;Sci. Rep.,2014

3. Overall structural model of NS5A protein from hepatitis C virus and modulation by mutations confering resistance of virus replication to cyclosporin A;Badillo;Biochemistry,2017

4. Novel benzidine and diamino fluorene prolinamide derivatives as potent hepatitis C virus NS5A inhibitors;Bae;Eur. J. Med. Chem.,2015

5. Efficient initiation of HCV RNA replication in cell culture;Blight;Science,2000

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress in Cyclic Aryliodonium Chemistry: Syntheses and Applications;Chemical Reviews;2023-01-17

2. Structure-activity relationship (SAR) studies on the mutagenic properties of 2,7-diaminofluorene and 2,7-diaminocarbazole derivatives;Bioorganic & Medicinal Chemistry Letters;2021-01